SNY - Sanofi

45
-1.220   -2.711%

Share volume: 4,470,674
Last Updated: 03-05-2026
Pharmaceutical Products/Pharmaceutical Preparations: 3.31%

PREVIOUS CLOSE
CHG
CHG%
$46.22
-1.22
-0.03%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
0%
Profitability 0%
Dept financing 0%
Liquidity 0%
Performance 0%
Performance
5 Days
-5.58%
1 Month
-5.92%
3 Months
-7.10%
6 Months
-3.85%
1 Year
-24.27%
2 Year
-5.62%
Key data
Stock price
$45.00
P/E Ratio 
23.91
DAY RANGE
$44.71 - $45.34
EPS 
N/A
52 WEEK RANGE
$44.62 - $60.12
52 WEEK CHANGE
-$24.05
MARKET CAP 
142.744 B
YIELD 
3.62%
SHARES OUTSTANDING 
2.537 B
DIVIDEND
$2.0369
EX-DIVIDEND DATE
05-09-2024
NEXT EARNINGS DATE
07-24-2025
BETA 
0.18
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$4,711,792
AVERAGE 30 VOLUME 
$5,204,099
Company detail
CEO: Paul Hudson
Region: US
Website: sanofi.com
Employees: 91,600
IPO year: 2002
Issue type: American Depository Receipt (ADR’s)
Market: XNAS
Industry: Pharmaceutical Products/Pharmaceutical Preparations
Sector: Manufacturing

Sanofi engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company has collaboration agreement with GlaxoSmithKline to develop a recombinant Covid-19 vaccine; and research collaboration with Stanford University School of Medicine to advance the understanding of immunology and inflammation.

Recent news